<DOC>
	<DOCNO>NCT01355341</DOCNO>
	<brief_summary>More specifically , present invention relate 'Herbal Preparation ' useful - Treatment Renal calculus - Reduction stone size &amp; surface area - The expulsion stone - Decreased need Analgesic ( Antiinflammatory Effect ) - Stops recurrence reformation renal</brief_summary>
	<brief_title>Safety Efficacy Herbmed Plus Patients withRenal Calculi</brief_title>
	<detailed_description>1 . Study duration 28 week 2 . No . Scheduled visit 8 visit 3 . Study product Dose , Group one-:1capsule ( 500 mg ) orally twice day meal 24 week . Group two- : placebo1capsule ( 500 mg ) orally twice day meal 24 week .</detailed_description>
	<mesh_term>Calculi</mesh_term>
	<mesh_term>Kidney Calculi</mesh_term>
	<mesh_term>Nephrolithiasis</mesh_term>
	<criteria>Age 1075 year ( Both inclusive ) Patients Renal calculus , diagnosis confirm plain Xray KUB &amp; /or ultrasound KUB/CT scan Abdomen Size calculi range 04 mm 09 mm Able willing give write informed consent comply requirement study protocol Patients reproductive potential ( male female ) willing use reliable mean contraception ( e.g hormonal contraceptive patch , intrauterine device physical barrier ) throughout study participation Patients cooperate &amp; give consent trial &amp; come regular follow . Patients acute condition renal calculus . Any systemic disease require medication surgery calculus condition . Complicated case Renal Calculi require surgical condition . Chronic current infectious disease limit chronic renal infection include active urinary tract infection.Uncontrolled diabetes , hypertension , symptomatic congestive heart failure , unstable angina pectoris , myocardial infarction Any urogenital disorder . Liver dysfunction , define total bilirubin 1.5 upper limit Normal , aspartate aminotransferase 2.5 upper limit Normal , alanine aminotransferase 2.5 upper limit Normal , Kidney disease , include serum creatinine level 1.5 upper limit Normal , Subjects herbal supplement stone disease ( plant extract preparation herbal medicine etc . ) within previous 3 month . Participated another clinical drug trial within 3 month recruitment . Pregnancy breast feeding Evidence significant uncontrolled concomitant disease Investigator 's opinion would preclude patient participation Currently active alcohol drug abuse history alcohol drug abuse within 24 week prior baseline Patients psychiatric illness condition would limit compliance study requirement Patients receive receive investigational drug within 30 day receive first dose study medication Subjects refuse sign inform consent document .</criteria>
	<gender>All</gender>
	<minimum_age>10 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>May 2011</verification_date>
	<keyword>RENAL CALCULI HERBMED PLUS</keyword>
</DOC>